[Effect of glafenin (Glifanan) on anticoagulant treatment with coumarin derivatives].
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D002986:Clinical Trials as Topic; D003374:Coumarins / Q000627:therapeutic use*; D006018:Glycols / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D010689:Phlebitis / Q000188:drug therapy; D010919:Placebos; D011804:Quinolines / Q000627:therapeutic use; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000925:Anticoagulants; D001593:Benzyl Compounds; D003374:Coumarins; D006018:Glycols; D010919:Placebos; D011804:Quinolines; D062367:ortho-Aminobenzoates
De invloed van glafenine (Glifanan) op antistollingsbehandeling met coumarine-derivaten